
Selective against cancer cells, activating for immunity
An oral botanical drug candidate that standardizes a new combination of herbs based on a Korean medicine formula. It induces selective cancer cell death without toxicity to normal cells while activating the immune system.
- Korea's first oral botanical anticancer IND
- 3 phase 1 trials completed
- Phase 2a approved in NSCLC
- Immune function human study completed

